Biogen
Fortune 1000 1978 #421 by revenue · BIIB United States Healthcare Pharmaceuticals biogen.com
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases.
Fortune 1000's description, shown to identify the company. We rate the name, not the business.
- Evocativity EVOC : not yet rated
- Not rated yet. This one needs the model pass.
- Brevity BREV : green
- 6 letters, 2 syllables. Up to seven letters is green, eight at two syllables too; up to ten yellow, eleven or more red.
- Greppability GREP : red
- Found inside 23 other dictionary words.
- Googlability GOOG : not yet rated
- Not rated yet. This one needs the model pass.
- Pronounceability PRON : not yet rated
- Not rated yet. This one needs the model pass.
- Spellability SPEL : not yet rated
- Not rated yet. This one needs the model pass.
- Verbability VERB : not yet rated
- Not rated yet. This one needs the model pass.
- Nominology (partial)
- 86
- Weighted across the 2 dimensions rated so far, not all seven. Not comparable with a complete card.
- Fluency
- –
- Needs pronounceability as well as brevity. From length alone it would put the weight of the fluency research behind a character count.
- PG grade
- – / 4
- Needs the model pass.
- Exact .com
- Owned
- Shape
- real word
- Length
- 6 chars, 2 syllables
- Distinctiveness
- Pending
This row is stitched from more than one source. Fortune 1000 supplied the company; forbes2000 filled year, country, and one_liner and S&P 500 / GICS filled subindustry.
Rubric version 2026.10.20-1.
This scores the name only. See Methodology.